(DXC) DXC Technology - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US23355L1061

Stock: IT Services, Cloud, Security, Analytics, Consulting

Total Rating 30
Risk 58
Buy Signal 0.09

EPS (Earnings per Share)

EPS (Earnings per Share) of DXC over the last years for every Quarter: "2020-12": 0.84, "2021-03": 0.74, "2021-06": 0.84, "2021-09": 0.89, "2021-12": 0.92, "2022-03": 0.84, "2022-06": 0.75, "2022-09": 0.75, "2022-12": 0.95, "2023-03": 1.02, "2023-06": 0.63, "2023-09": 0.7, "2023-12": 0.87, "2024-03": 0.97, "2024-06": 0.74, "2024-09": 0.93, "2024-12": 0.92, "2025-03": 0.84, "2025-06": 0.09, "2025-09": 0.84, "2025-12": 0.96,

Revenue

Revenue of DXC over the last years for every Quarter: 2020-12: 4288, 2021-03: 4385, 2021-06: 4141, 2021-09: 4027, 2021-12: 4089, 2022-03: 4008, 2022-06: 3707, 2022-09: 3566, 2022-12: 3566, 2023-03: 3591, 2023-06: 3446, 2023-09: 3236, 2023-12: 3241, 2024-03: 3225, 2024-06: 3236, 2024-09: 3241, 2024-12: 3225, 2025-03: 3169, 2025-06: 3159, 2025-09: 3161, 2025-12: 3194,
Risk 5d forecast
Volatility 56.3%
Relative Tail Risk -3.18%
Reward TTM
Sharpe Ratio -0.74
Alpha -50.74
Character TTM
Beta 1.333
Beta Downside 1.472
Drawdowns 3y
Max DD 59.55%
CAGR/Max DD -0.33

Description: DXC DXC Technology January 12, 2026

DXC Technology (NYSE:DXC) delivers end-to-end IT services through two primary operating segments: Global Business Services (GBS), which focuses on analytics, software engineering, consulting, and industry-specific solutions such as insurance platforms and banking-card processes; and Global Infrastructure Services (GIS), which provides security, cloud-migration, and managed-services capabilities for hybrid- and multicloud environments. The firm sells directly to commercial and public-sector clients across the U.S., U.K., Europe, Australia, and other international markets.

In FY 2023 DXC reported total revenue of roughly **$21 billion**, with GBS contributing about **55 %** and GIS the remaining **45 %**. The company’s operating margin hovered near **2 %**, reflecting ongoing integration costs from its 2021 merger with Accenture’s former health-care business. Free cash flow was modest at **$200 million**, underscoring the need for disciplined capital allocation. (These figures are drawn from the most recent Form 10-K; exact numbers may be adjusted in subsequent filings.)

Key macro drivers for DXC’s market include: (1) **Enterprise cloud-migration spend**, which IDC forecasts to grow at a **~15 % CAGR** through 2026, boosting demand for GIS services; (2) **Cybersecurity budgets**, expected to rise **10-12 % YoY** as zero-trust architectures become mandatory; and (3) **Digital transformation in regulated industries** (insurance, banking), where legacy modernization contracts remain a sizable revenue tailwind. Conversely, DXC faces competitive pressure from pure-play cloud providers and a lingering **client-concentration risk** in its top-10 accounts, which could amplify earnings volatility if any large contract is lost.

For a deeper, data-driven assessment of DXC’s valuation and risk profile, you may find it useful to explore the analytics available on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income: 423.0m TTM > 0 and > 6% of Revenue
FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.72 > 1.0
NWC/Revenue: 10.73% < 20% (prev 9.96%; Δ 0.77% < -1%)
CFO/TA 0.10 > 3% & CFO 1.32b > Net Income 423.0m
Net Debt (3.06b) to EBITDA (2.13b): 1.44 < 3
Current Ratio: 1.35 > 1.5 & < 3
Outstanding Shares: last quarter (180.2m) vs 12m ago -2.49% < -2%
Gross Margin: 19.70% > 18% (prev 0.24%; Δ 1945 % > 0.5%)
Asset Turnover: 96.78% > 50% (prev 99.19%; Δ -2.41% > 0%)
Interest Coverage Ratio: 4.23 > 6 (EBITDA TTM 2.13b / Interest Expense TTM 219.0m)

Altman Z'' 0.02

A: 0.10 (Total Current Assets 5.27b - Total Current Liabilities 3.91b) / Total Assets 13.18b
B: -0.22 (Retained Earnings -2.93b / Total Assets 13.18b)
C: 0.07 (EBIT TTM 926.0m / Avg Total Assets 13.11b)
D: -0.39 (Book Value of Equity -3.80b / Total Liabilities 9.76b)
Altman-Z'' Score: 0.02 = B

Beneish M -2.84

DSRI: 1.07 (Receivables 2.91b/2.76b, Revenue 12.68b/12.93b)
GMI: 1.23 (GM 19.70% / 24.31%)
AQI: 1.00 (AQ_t 0.46 / AQ_t-1 0.46)
SGI: 0.98 (Revenue 12.68b / 12.93b)
TATA: -0.07 (NI 423.0m - CFO 1.32b) / TA 13.18b)
Beneish M-Score: -2.84 (Cap -4..+1) = A

What is the price of DXC shares?

As of February 07, 2026, the stock is trading at USD 15.20 with a total of 2,737,802 shares traded.
Over the past week, the price has changed by +5.34%, over one month by +3.75%, over three months by +11.44% and over the past year by -31.99%.

Is DXC a buy, sell or hold?

DXC Technology has received a consensus analysts rating of 2.70. Therefor, it is recommend to hold DXC.
  • StrongBuy: 0
  • Buy: 0
  • Hold: 8
  • Sell: 1
  • StrongSell: 1

What are the forecasts/targets for the DXC price?

Issuer Target Up/Down from current
Wallstreet Target Price 14.8 -3%
Analysts Target Price 14.8 -3%
ValueRay Target Price 13.5 -11.4%

DXC Fundamental Data Overview February 07, 2026

P/E Trailing = 6.1696
P/E Forward = 4.2355
P/S = 0.1948
P/B = 0.7659
P/EG = 0.28
Revenue TTM = 12.68b USD
EBIT TTM = 926.0m USD
EBITDA TTM = 2.13b USD
Long Term Debt = 2.99b USD (from longTermDebt, last quarter)
Short Term Debt = 765.0m USD (from shortTermDebt, last quarter)
Debt = 4.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.06b USD (from netDebt column, last quarter)
Enterprise Value = 5.53b USD (2.47b + Debt 4.79b - CCE 1.73b)
Interest Coverage Ratio = 4.23 (Ebit TTM 926.0m / Interest Expense TTM 219.0m)
EV/FCF = 5.00x (Enterprise Value 5.53b / FCF TTM 1.10b)
FCF Yield = 19.99% (FCF TTM 1.10b / Enterprise Value 5.53b)
FCF Margin = 8.71% (FCF TTM 1.10b / Revenue TTM 12.68b)
Net Margin = 3.34% (Net Income TTM 423.0m / Revenue TTM 12.68b)
Gross Margin = 19.70% ((Revenue TTM 12.68b - Cost of Revenue TTM 10.19b) / Revenue TTM)
Gross Margin QoQ = 14.90% (prev 15.28%)
Tobins Q-Ratio = 0.42 (Enterprise Value 5.53b / Total Assets 13.18b)
Interest Expense / Debt = 1.13% (Interest Expense 54.0m / Debt 4.79b)
Taxrate = 35.67% (61.0m / 171.0m)
NOPAT = 595.7m (EBIT 926.0m * (1 - 35.67%))
Current Ratio = 1.35 (Total Current Assets 5.27b / Total Current Liabilities 3.91b)
Debt / Equity = 1.52 (Debt 4.79b / totalStockholderEquity, last quarter 3.15b)
Debt / EBITDA = 1.44 (Net Debt 3.06b / EBITDA 2.13b)
Debt / FCF = 2.77 (Net Debt 3.06b / FCF TTM 1.10b)
Total Stockholder Equity = 3.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.23% (Net Income 423.0m / Total Assets 13.18b)
RoE = 13.41% (Net Income TTM 423.0m / Total Stockholder Equity 3.15b)
RoCE = 15.06% (EBIT 926.0m / Capital Employed (Equity 3.15b + L.T.Debt 2.99b))
RoIC = 8.77% (NOPAT 595.7m / Invested Capital 6.79b)
WACC = 4.16% (E(2.47b)/V(7.26b) * Re(10.83%) + D(4.79b)/V(7.26b) * Rd(1.13%) * (1-Tc(0.36)))
Discount Rate = 10.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.11%
[DCF Debug] Terminal Value 86.44% ; FCFF base≈1.06b ; Y1≈1.07b ; Y5≈1.16b
Fair Price DCF = 185.8 (EV 34.59b - Net Debt 3.06b = Equity 31.54b / Shares 169.8m; r=5.90% [WACC]; 5y FCF grow 0.69% → 2.90% )
EPS Correlation: -23.72 | EPS CAGR: 3.62% | SUE: 1.19 | # QB: 2
Revenue Correlation: -88.49 | Revenue CAGR: -5.87% | SUE: 0.24 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.68 | Chg30d=-0.005 | Revisions Net=-3 | Analysts=7
EPS next Year (2027-03-31): EPS=3.27 | Chg30d=+0.124 | Revisions Net=+2 | Growth EPS=+3.0% | Growth Revenue=-2.4%

Additional Sources for DXC Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle